Home Top Movers Moleculin Biotech, Inc. (MBRX) stock is rising today: What’s Going on?

Moleculin Biotech, Inc. (MBRX) stock is rising today: What’s Going on?

Moleculin Biotech, Inc. (MBRX) announced today that it has been granted Rare Pediatric Disease Designation (RPD) for WP1066 to treat ependymoma after which the MBRX stock price saw an uptrend of 7.18% to reach $4.16 a share at the time of this writing. MBRX stock was also green in the previous trading session and went up by 0.56% at closing. Let’s understand more about MBRX stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Rare Pediatric Disease Designation:

Moleculin Biotech, Inc is a clinical-stage company working on the development of oncology drugs in order to treat patients suffering from highly resistant tumors and viruses in the U.S.Investors are responding to the news announced by the MBRX stock today related to its p-STAT3 inhibitor, WP1066 which is used to treat ependymoma. Ependymoma is a rare tumor that usually forms in the brain and spinal cord and occurs at any age but usually occurs in young children.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

Moleculin stock would be able to receive the voucher in connection with the FDA approval of WP1066 which then may be redeemed to receive the priority review for a subsequent marketing application for other product candidates. The MBRX stock can also sell or transfer that voucher.

Management Viewpoint:

Management thinks that the Rare Pediatric Disease Designation grant by FDA for WP1066 is the major milestone. Management is looking forward to the expansion and development of WP1066 in the future and firmly believes that the WP1066 has the great potential to treat pediatric patients suffering from ependymoma.

Rare Pediatric Disease

Rare Pediatric Disease a serious life-threatening disease that usually targets individuals aged from birth to 18 years. Nearly 200,000 people are affected by this disease in the United States of America.

Previous News of MBRX stock:

On April 6, 2021, Moleculin stock did announce the engagement of  IQVIA Biotech in order to manage the potential clinical trials of WP1122 by the MBRX stock to treat COVID-19. The purpose of this engagement is to check the potential of  WP1122 against the deadly pandemic.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

So far so good for MBRX as far as market sentiment is concerned. It seems that momentum was already building for MBRX stock and recent news has added more hype to the rising stock price of Moleculin stock. Recent developments point to the growth of MBRX stock but a deep fundamental, as well as technical analysis, is recommended for this stock.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

Himax Technologies, Inc. (HIMX) Stock Climbing After Promising Q1 2021 Financial Reports

Himax Technologies, Inc. (HIMX) stock prices were down by 6.97% as of the market closing on May 5th 2021, bringing the price per share...

Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

BioCryst Pharmaceuticals, Inc. (BCRX) announced its first-quarter 2021 financial results after which the BCRX stock happened to be green as its per-share price went...

Precipio, Inc. (PRPO) Stock Trending Up Following Successful Launch of Covid-19 Antibody Testing Kit

Precipio, Inc. (PRPO) stock prices were down 3.62% as of the market closing on ay 5th 2021, bringing the price per hare down to...

Shares of Cinedigm Corp. (CIDM) are climbing high in the premarket. What’s Going On?

Cinedigm (NASDAQ:CIDM), a distributor of various movies, television and other digital content, managing a library of distribution rights to several thousand titles and different...

Why Stealth BioTherapeutics Corp (MITO) stock is soaring in Pre-Market today?

Stealth BioTherapeutics Corp (MITO) presented the data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting, which is collected...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.